Kyverna Therapeutics
KYTX
KYTX
88 hedge funds and large institutions have $240M invested in Kyverna Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 90 → 88 (-2)
53% less call options, than puts
Call options by funds: $48K | Put options by funds: $102K
69% less capital invested
Capital invested by funds: $762M → $240M (-$523M)
Holders
88
Holding in Top 10
4
Calls
$48K
Puts
$102K
Top Buyers
| 1 | +$9.13M | |
| 2 | +$7.88M | |
| 3 | +$5.64M | |
| 4 |
BlackRock
New York
|
+$5.28M |
| 5 |
DM
Deerfield Management
New York
|
+$3.9M |
Top Sellers
| 1 | -$34.7M | |
| 2 | -$22.7M | |
| 3 | -$15M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$12.4M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$11.8M |